Pharmafile Logo
Pharmafocus logo
Advanced Search

Aslan licences promising cancer drug from Bristol-Myers Squibb

November 7, 2011
Research and Development, Sales and Marketing Aslan, BMS, Cancer

Bristol-Myers Squibb has licensed one of its investigational oncology compounds, for the treatment of multiple solid tumours, to Singapore-based Aslan …

News

Xarelto gains lucrative new licence from FDA

November 7, 2011
Sales and Marketing

The FDA has approved Bayer/J&J’s Xarelto once-daily pill for stroke prevention in patients with an abnormal heart rhythm. The US …

News
Ranbayx image

Ranbaxy to collaborate with Teva on generic Lipitor in US?

November 7, 2011
Manufacturing and Production, Sales and Marketing Lipitor, Pfizer, Ranbaxy, Teva

Israeli drugmaker Teva Pharmaceutical could get an unexpected boost from an earlier-than-expected launch of its generic version of Pfizer’s cholesterol …

News
steve_hobbsrgb

Steve Hobbs joins Apodi senior management team

November 4, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Steve Hobbs has joined Apodi’s senior management team as director of business and account development. Steve has over 30 years …

Appointment

Graham Higson joins NDA Group to lead Regulatory and HTA Advisory Board

November 4, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NDA

GE Healthcare and ex AstraZeneca Head of Global Regulatory Affairs, Graham Higson, will join NDA Group in January 2012 to …

Appointment
Hamburg FDA image

FDA boasts better approval rates than Europe

November 4, 2011
Medical Communications, Research and Development FDA, approvals

US regulator the FDA has approved more drugs and at a faster rate than its European counterpart.A new report by …

News
Tyverb

Cancer drugs should not receive special funding – MS Society

November 4, 2011
Sales and Marketing ABPI, Cancer Drugs Fund, MS Society, NICE

 

News

GSK, Pfizer joint venture to start manufacturing ops in Russia

November 4, 2011
Manufacturing and Production GSK, Pfizer, manufacturing

A joint venture set up by GlaxoSmithKline and Pfizer is planning to start manufacturing in Russia thanks to a partnership …

News

Ketchum wins International Consultancy of the Year award

November 3, 2011
Medical Communications Ketchum, Ketchum Pleon, PR

Ketchum Pleon has accepted the International Consultancy of the Year award on behalf of the global firm Ketchum at the …

News

GSK pays $3 billion to settle US marketing probe

November 3, 2011
Sales and Marketing GSK, compliance, federal investigation

GlaxoSmithKline has agreed to pay $3 billion to settle US government investigations into the sales and marketing of diabetes drug …

News

Synergy Vision hires Caroline Loder and Natalie Ferguson

November 3, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Synergy Vision

Synergy Vision, the London-based medical communications agency, has hired Caroline Loder as a senior medical writer and Natalie Ferguson as a …

Appointment
e

Teva sees modest growth as US sales fall

November 3, 2011
Business Services, Sales and Marketing Teva, generics

Sales growth at Teva was modest in Q3, rising 2% to $4.34 billion, with growth predominately coming from branded drugs.This …

News

Doctors decry cost-cutting in HIV treatment

November 2, 2011
Sales and Marketing HIV, NHS, Reyataz

Doctors in London are opposing a decision to switch HIV patients to a cheaper drug, saying it could harm patients. …

News

Richard Daniell appointed as managing director of Teva UK

November 2, 2011
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Teva Pharmaceutical

Richard Daniell has been appointed as managing director for Teva UK, and will be responsible for all Teva’s commercial activities …

Appointment
Sanofi HQ pic

Sanofi to become world’s biggest drug maker

November 2, 2011
Medical Communications, Research and Development, Sales and Marketing Pfizer, Sanofi, top 10

Sanofi will replace Pfizer as the world’s biggest drug maker by revenue next year, according to new forecasts.  Pfizer’s nine-year …

News
pfizer_hq_street_web

Prevnar and Lyrica lift Pfizer results

November 1, 2011
Research and Development, Sales and Marketing Lipitor, Lyrica, Pfizer, Prevnar, patent expiry

Strong sales of Lyrica and its Prevnar vaccines coupled with favourable exchange rates have helped Pfizer deliver a strong quarter.  …

News
picture_2

Lundbeck appoints two new R&D vice presidents

November 1, 2011
Research and Development Lundbeck, R&D

Lundbeck has appointed Jens Peter Balling and Iman Barilero as vice presidents of its research and development organisation. The new …

Appointment
Obama image

Obama takes action to curb medicine shortages

November 1, 2011
Manufacturing and Production, Research and Development, Sales and Marketing FDA, Obama, drugs

US President Barack Obama has ordered the FDA and Department of Justice to take action to reduce and prevent medicine …

News
Lonza image

Lonza sees continued recovery in third quarter

November 1, 2011
Manufacturing and Production, Sales and Marketing Lonza, Q3, manufacturing and production

Revenue growth at contract manufacturing organisation Lonza in the third quarter was once again undermined by the strength of the …

News
Pradaxa

NICE U-turn on Boehringer’s Pradaxa

November 1, 2011
Sales and Marketing NICE, Pradaxa

NICE is now recommending Boehringer Ingelheim’s Pradaxa for stroke prevention after initially rejecting the drug on cost-effectiveness issues. NICE has …

News
The Gateway to Local Adoption Series

Latest content

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026